ReP USP - Resultado da busca

Filtros : "Medicinal Chemistry" "ENZIMAS" Removido: "FCF" Limpar

Filtros

Artigo de periodico
In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus (2021)
Martins, Michelle C.M.R.; Pantaleão, Simone Queiroz ; Almeida, Michell de Oliveira ; Weber, Karen C; Honório, Káthia Maria
Fonte: Medicinal Chemistry. Unidades: EACH, IQSC
Assuntos: PÂNCREAS, ENZIMAS, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Michelle C.M.R. et al. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus. Medicinal Chemistry, v. 17, n. 3, p. 247-263, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406416666200129151256. Acesso em: 12 set. 2024.
APA
Martins, M. C. M. R., Pantaleão, S. Q., Almeida, M. de O., Weber, K. C., & Honório, K. M. (2021). In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus. Medicinal Chemistry, 17( 3), 247-263. doi:10.2174/1573406416666200129151256
NLM
Martins MCMR, Pantaleão SQ, Almeida M de O, Weber KC, Honório KM. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus [Internet]. Medicinal Chemistry. 2021 ; 17( 3): 247-263.[citado 2024 set. 12 ] Available from: https://doi.org/10.2174/1573406416666200129151256
Vancouver
Martins MCMR, Pantaleão SQ, Almeida M de O, Weber KC, Honório KM. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus [Internet]. Medicinal Chemistry. 2021 ; 17( 3): 247-263.[citado 2024 set. 12 ] Available from: https://doi.org/10.2174/1573406416666200129151256
Artigo de periodico
Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana (2020)
Alves, Krisnna M.A. ; Cardoso, Fábio José Bonfim ; Honório, Káthia Maria ; Molfetta, Fábio A. de
Fonte: Medicinal Chemistry. Unidade: EACH
Assuntos: LEISHMANIA MEXICANA, ENZIMAS, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Krisnna M.A. et al. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana. Medicinal Chemistry, v. 16, n. 6, p. 784-795, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573406415666190712111139. Acesso em: 12 set. 2024.
APA
Alves, K. M. A., Cardoso, F. J. B., Honório, K. M., & Molfetta, F. A. de. (2020). Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana. Medicinal Chemistry, 16( 6), 784-795. doi:10.2174/1573406415666190712111139
NLM
Alves KMA, Cardoso FJB, Honório KM, Molfetta FA de. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana [Internet]. Medicinal Chemistry. 2020 ; 16( 6): 784-795.[citado 2024 set. 12 ] Available from: https://doi.org/10.2174/1573406415666190712111139
Vancouver
Alves KMA, Cardoso FJB, Honório KM, Molfetta FA de. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana [Internet]. Medicinal Chemistry. 2020 ; 16( 6): 784-795.[citado 2024 set. 12 ] Available from: https://doi.org/10.2174/1573406415666190712111139

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2024